Jeffrey S. Berger, MD, MS, FAHA, FACC
Print Faculty Schedule:
|
New York, New York
Associate Professor of Medicine and Surgery
New York University School of Medicine
Director of Cardiovascular Thrombosis
New York University Langone Medical Center
|
SCHEDULE FOR VEITHsymposium™ |
Wednesday, November 16, 2016 |
Presenter
Why LDL-C (Or Non-HDL-C) Levels Are Important Guides To Treatment And Should Be Followed In Primary And Secondary Event Prevention For Vascular Patients At Risk: Coronary Lesions Regress When LDL-C Is <80 mm/dL
7:16 AM - 7:21 AM
|
Presenter
New Key Findings From The JUPITER Trial: Statins (Crestor) Have Variability In Their LDL-C Lowering Ability; The Degree Of Cardiovascular Risk Reduction Correlates With The Percent LDL-C Reduction: Therapeutic Implications
7:28 AM - 7:33 AM
|
Friday, November 18, 2016 |
Presenter
What Is New In Antiplatelet Treatment Of Vascular Patients: Which Drugs In Which Situation: New Drugs And What Does The EUCLID Trial Tell Us
2:38 PM - 2:43 PM
|
previous | next |